Drug profile · INN
cerliponase alfa
BRINEURA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cerliponase alfa (BRINEURA) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN cerliponase alfa
Brand BRINEURA
Route INJECTION
Formulation INJECTABLE
ATC code A16AB
Originator BioMarin International Limited
Frequently asked questions
What is cerliponase alfa?
cerliponase alfa (BRINEURA) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cerliponase alfa?
BRINEURA is a marketed brand name for cerliponase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cerliponase alfa?
cerliponase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.